Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. (PRTK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PRTK · as of Jun 9, 2026
Key Statistics
Explore Paratek Pharmaceuticals, Inc. Data
prtk stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 71.4%
Competitors & Peers
prtk competitorsPRTK
ATYR
DBTX
GRAY
KNTE
NGMStock Performance
Full HistoryAbout Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc. a biopharmaceutical firm headquartered in Boston, Massachusetts, and founded in 1996, is actively engaged in the commercialization of its products. The company's core mi…
what is paratek pharmaceuticals, inc. · prtk stock overview · paratek pharmaceuticals, inc. company profile · who is paratek pharmaceuticals, inc. ceo · prtk NASDAQ · paratek pharmaceuticals, inc. headquarters · paratek pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Paratek Pharmaceuticals, Inc. (PRTK) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 3, 2009. As of the latest trading session, PRTK stock price is $2.23, with a market capitalization of $127.8M. The stock has returned -26.64% over the past 12 months and +19.89% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Paratek Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Paratek Pharmaceuticals, Inc. reported revenue of $150.8M and net income of -$63.6M. For detailed data — including Paratek Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Paratek Pharmaceuticals, Inc. (PRTK) stock price is $2.23. The stock is traded on NASDAQ under the ticker symbol PRTK. The 52-week range is $1.29 – $3.65.